These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 8513399
21. Laser ablation-inductively coupled plasma-mass spectrometry imaging of white and gray matter iron distribution in Alzheimer's disease frontal cortex. Hare DJ, Raven EP, Roberts BR, Bogeski M, Portbury SD, McLean CA, Masters CL, Connor JR, Bush AI, Crouch PJ, Doble PA. Neuroimage; 2016 Aug 15; 137():124-131. PubMed ID: 27233149 [Abstract] [Full Text] [Related]
22. Neurochemical changes in white matter. Aged human brain and Alzheimer's disease. Malone MJ, Szoke MC. Arch Neurol; 1985 Nov 15; 42(11):1063-6. PubMed ID: 4051835 [Abstract] [Full Text] [Related]
23. From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry. Grimm MO, Grösgen S, Riemenschneider M, Tanila H, Grimm HS, Hartmann T. J Chromatogr A; 2011 Oct 21; 1218(42):7713-22. PubMed ID: 21872257 [Abstract] [Full Text] [Related]
24. Short-Term Fish Oil Treatment Changes the Composition of Phospholipids While Not Affecting the Expression of Mfsd2a Omega-3 Transporter in the Brain and Liver of the 5xFAD Mouse Model of Alzheimer's Disease. Milanovic D, Petrovic S, Brkic M, Avramovic V, Perovic M, Ivkovic S, Glibetic M, Kanazir S. Nutrients; 2018 Sep 06; 10(9):. PubMed ID: 30200627 [Abstract] [Full Text] [Related]
28. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Scheltens P, Barkhof F, Valk J, Algra PR, van der Hoop RG, Nauta J, Wolters EC. Brain; 1992 Jun 06; 115 ( Pt 3)():735-48. PubMed ID: 1628199 [Abstract] [Full Text] [Related]
29. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter. DeCarli C, Grady CL, Clark CM, Katz DA, Brady DR, Murphy DG, Haxby JV, Salerno JA, Gillette JA, Gonzalez-Aviles A, Rapoport SI. J Neurol Neurosurg Psychiatry; 1996 Feb 06; 60(2):158-67. PubMed ID: 8708645 [Abstract] [Full Text] [Related]
32. Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer's disease. Sodeyama N, Itoh Y, Suematsu N, Matsushita M, Otomo E, Mizusawa H, Yamada M. J Neurol Neurosurg Psychiatry; 1998 Apr 06; 64(4):548-51. PubMed ID: 9576554 [Abstract] [Full Text] [Related]
36. Content and fatty acid composition of cardiolipin in the brain of patients with Alzheimer's disease. Guan ZZ, Söderberg M, Sindelar P, Edlund C. Neurochem Int; 1994 Sep 06; 25(3):295-300. PubMed ID: 7833797 [Abstract] [Full Text] [Related]
37. Dietary DHA supplementation causes selective changes in phospholipids from different brain regions in both wild type mice and the Tg2576 mouse model of Alzheimer's disease. Bascoul-Colombo C, Guschina IA, Maskrey BH, Good M, O'Donnell VB, Harwood JL. Biochim Biophys Acta; 2016 Jun 06; 1861(6):524-37. PubMed ID: 26968097 [Abstract] [Full Text] [Related]
39. A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system. Gulyás B, Makkai B, Kása P, Gulya K, Bakota L, Várszegi S, Beliczai Z, Andersson J, Csiba L, Thiele A, Dyrks T, Suhara T, Suzuki K, Higuchi M, Halldin C. Neurochem Int; 2009 Jan 06; 54(1):28-36. PubMed ID: 18984021 [Abstract] [Full Text] [Related]
40. [Changes of nuclear factor and inflammatory chemotactic factors in brain of patients with Alzheimer's disease]. Liao Y, Guan ZZ, Ravid R. Zhonghua Bing Li Xue Za Zhi; 2011 Sep 06; 40(9):585-9. PubMed ID: 22177240 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]